Pradaxa FDA Approved Drugs
PRADAXA [Dabigatran Etexilate MesylateC34H41N7O5CH4O3S]
RX
- eq 110mg base (oral capsule)
eq 150mg base (oral capsule)
eq 75mg base (oral capsule)
Boehringer IngelheimNov 20, 2015
- Method of reversing the anticoagulant effect of dabigatran using idarucizumab.
- Prophylaxis or treatment of venous and arterial thrombotic disease.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.